The Italian pharmaceutical company Angelini Pharma announced on January 4, 2021, that it will acquire emerging Swiss biotech company
Continue Reading The New Exclusive European Licensee of Cenobamate: Angelini Pharma Acquires Emerging Swiss Biotech Company Arvelle Therapeutics
Mergers & Acquisitions
Cadent Therapeutics Acquired by Novartis for Up to $770 Million
By Aydin H. Harston on
Posted in Trends & Analysis
Cadent Therapeutics, a Cambridge, Massachusetts-based, privately held clinical stage biopharmaceutical company focused on the development of therapies for the…
Continue Reading Cadent Therapeutics Acquired by Novartis for Up to $770 Million